Cargando…

LeishIF3d is a non-canonical cap-binding protein in Leishmania

Translation of most cellular mRNAs in eukaryotes proceeds through a cap-dependent pathway, whereby the cap-binding complex, eIF4F, anchors the pre-initiation complex at the 5′ end of mRNAs driving translation initiation. The genome of Leishmania encodes a large repertoire of cap-binding complexes th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bose, Priyanka, Baron, Nofar, Pullaiahgari, Durgeshwar, Ben-Zvi, Anat, Shapira, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266417/
https://www.ncbi.nlm.nih.gov/pubmed/37325473
http://dx.doi.org/10.3389/fmolb.2023.1191934
_version_ 1785058736070459392
author Bose, Priyanka
Baron, Nofar
Pullaiahgari, Durgeshwar
Ben-Zvi, Anat
Shapira, Michal
author_facet Bose, Priyanka
Baron, Nofar
Pullaiahgari, Durgeshwar
Ben-Zvi, Anat
Shapira, Michal
author_sort Bose, Priyanka
collection PubMed
description Translation of most cellular mRNAs in eukaryotes proceeds through a cap-dependent pathway, whereby the cap-binding complex, eIF4F, anchors the pre-initiation complex at the 5′ end of mRNAs driving translation initiation. The genome of Leishmania encodes a large repertoire of cap-binding complexes that fulfill a variety of functions possibly involved in survival along the life cycle. However, most of these complexes function in the promastigote life form that resides in the sand fly vector and decrease their activity in amastigotes, the mammalian life form. Here we examined the possibility that LeishIF3d drives translation in Leishmania using alternative pathways. We describe a non-canonical cap-binding activity of LeishIF3d and examine its potential role in driving translation. LeishIF3d is required for translation, as reducing its expression by a hemizygous deletion reduces the translation activity of the LeishIF3d(+/−) mutant cells. Proteomic analysis of the mutant cells highlights the reduced expression of flagellar and cytoskeletal proteins, as reflected in the morphological changes observed in the mutant cells. Targeted mutations in two predicted alpha helices diminish the cap-binding activity of LeishIF3d. Overall, LeishIF3d could serve as a driving force for alternative translation pathways, although it does not seem to offer an alternative pathway for translation in amastigotes.
format Online
Article
Text
id pubmed-10266417
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102664172023-06-15 LeishIF3d is a non-canonical cap-binding protein in Leishmania Bose, Priyanka Baron, Nofar Pullaiahgari, Durgeshwar Ben-Zvi, Anat Shapira, Michal Front Mol Biosci Molecular Biosciences Translation of most cellular mRNAs in eukaryotes proceeds through a cap-dependent pathway, whereby the cap-binding complex, eIF4F, anchors the pre-initiation complex at the 5′ end of mRNAs driving translation initiation. The genome of Leishmania encodes a large repertoire of cap-binding complexes that fulfill a variety of functions possibly involved in survival along the life cycle. However, most of these complexes function in the promastigote life form that resides in the sand fly vector and decrease their activity in amastigotes, the mammalian life form. Here we examined the possibility that LeishIF3d drives translation in Leishmania using alternative pathways. We describe a non-canonical cap-binding activity of LeishIF3d and examine its potential role in driving translation. LeishIF3d is required for translation, as reducing its expression by a hemizygous deletion reduces the translation activity of the LeishIF3d(+/−) mutant cells. Proteomic analysis of the mutant cells highlights the reduced expression of flagellar and cytoskeletal proteins, as reflected in the morphological changes observed in the mutant cells. Targeted mutations in two predicted alpha helices diminish the cap-binding activity of LeishIF3d. Overall, LeishIF3d could serve as a driving force for alternative translation pathways, although it does not seem to offer an alternative pathway for translation in amastigotes. Frontiers Media S.A. 2023-05-30 /pmc/articles/PMC10266417/ /pubmed/37325473 http://dx.doi.org/10.3389/fmolb.2023.1191934 Text en Copyright © 2023 Bose, Baron, Pullaiahgari, Ben-Zvi and Shapira. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Bose, Priyanka
Baron, Nofar
Pullaiahgari, Durgeshwar
Ben-Zvi, Anat
Shapira, Michal
LeishIF3d is a non-canonical cap-binding protein in Leishmania
title LeishIF3d is a non-canonical cap-binding protein in Leishmania
title_full LeishIF3d is a non-canonical cap-binding protein in Leishmania
title_fullStr LeishIF3d is a non-canonical cap-binding protein in Leishmania
title_full_unstemmed LeishIF3d is a non-canonical cap-binding protein in Leishmania
title_short LeishIF3d is a non-canonical cap-binding protein in Leishmania
title_sort leishif3d is a non-canonical cap-binding protein in leishmania
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266417/
https://www.ncbi.nlm.nih.gov/pubmed/37325473
http://dx.doi.org/10.3389/fmolb.2023.1191934
work_keys_str_mv AT bosepriyanka leishif3disanoncanonicalcapbindingproteininleishmania
AT baronnofar leishif3disanoncanonicalcapbindingproteininleishmania
AT pullaiahgaridurgeshwar leishif3disanoncanonicalcapbindingproteininleishmania
AT benzvianat leishif3disanoncanonicalcapbindingproteininleishmania
AT shapiramichal leishif3disanoncanonicalcapbindingproteininleishmania